• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支架内再狭窄复发,其起源明确,治疗存在不确定性。

Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatment.

作者信息

Piraino Davide, Cimino Giuliana, Buccheri Dario, Dendramis Gregory, Andolina Giuseppe, Cortese Bernardo

机构信息

Interventional Cardiology, "P. Giaccone" University Hospital of Palermo, Italy.

Interventional Cardiology, "P. Giaccone" University Hospital of Palermo, Italy.

出版信息

Int J Cardiol. 2017 Mar 1;230:91-96. doi: 10.1016/j.ijcard.2016.12.073. Epub 2016 Dec 22.

DOI:10.1016/j.ijcard.2016.12.073
PMID:28038808
Abstract

Treatment of recurrent in-stent restenosis is a real brainteaser for the interventional cardiologist who cannot resort to the guidelines to have indications about the type of treatment to be preferred. The use of intracoronary imaging may provide insights into the underlying mechanisms of this complication and use of drug-coated balloons may be a valid alternative and especially a thoughtful treatment when the repeated and perseverant use of drug-eluting stents clearly fails. In this setting, we present a review of the literature about this interesting topic, going deep into the heart of the problem, its origin and possible treatment options.

摘要

对于无法依据指南来确定首选治疗类型的介入心脏病专家而言,复发性支架内再狭窄的治疗着实是个棘手难题。冠状动脉内成像的应用或许能为这一并发症的潜在机制提供见解,当药物洗脱支架的反复持续使用明显无效时,药物涂层球囊的应用可能是一种有效的替代方法,尤其是一种经过深思熟虑的治疗手段。在此背景下,我们针对这一有趣的话题展开文献综述,深入探讨问题的核心、其根源以及可能的治疗选择。

相似文献

1
Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatment.支架内再狭窄复发,其起源明确,治疗存在不确定性。
Int J Cardiol. 2017 Mar 1;230:91-96. doi: 10.1016/j.ijcard.2016.12.073. Epub 2016 Dec 22.
2
A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.紫杉醇涂层球囊导管与常规球囊血管成形术治疗金属裸支架再狭窄和药物洗脱支架再狭窄患者的多中心随机比较。
Am Heart J. 2013 Sep;166(3):527-33. doi: 10.1016/j.ahj.2013.07.002. Epub 2013 Aug 13.
3
Non-ST-segment elevation myocardial infarction related to vulnerable neoatheroma in bare-metal stents 2 years after percutaneous coronary intervention of a coronary saphenous vein graft.冠状动脉大隐静脉移植血管经皮冠状动脉介入治疗2年后,裸金属支架内易损新生动脉粥样硬化相关的非ST段抬高型心肌梗死
JACC Cardiovasc Interv. 2014 Aug;7(8):e95-6. doi: 10.1016/j.jcin.2013.12.214. Epub 2014 Jul 30.
4
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).紫杉醇涂层球囊与球囊血管成形术治疗的长期结果:PEPCAD-DES 研究的见解(使用 SeQuent Please 紫杉醇涂层经皮腔内冠状动脉血管成形术 [PTCA] 导管治疗药物洗脱支架 [DES] 支架内再狭窄)。
JACC Cardiovasc Interv. 2015 Nov;8(13):1695-700. doi: 10.1016/j.jcin.2015.07.023.
5
Repeat in-stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons.药物洗脱球囊成功治疗的分叉病变中药物洗脱支架的支架内再狭窄复发
Cardiovasc Revasc Med. 2013 Mar-Apr;14(2):106-8. doi: 10.1016/j.carrev.2012.10.009. Epub 2012 Nov 26.
6
Comment on: "a multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis".关于《紫杉醇涂层球囊导管与传统球囊血管成形术治疗裸金属支架再狭窄和药物洗脱支架再狭窄患者的多中心随机对照研究》的评论
Am Heart J. 2014 Mar;167(3):e9. doi: 10.1016/j.ahj.2013.11.007. Epub 2013 Nov 22.
7
Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.冠状动脉支架内再狭窄的当前认识。病理生理学、临床表现、诊断检查及管理。
Z Kardiol. 2005 Nov;94(11):772-90. doi: 10.1007/s00392-005-0299-x.
8
Reply to comment on: "a multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis".对关于“紫杉醇涂层球囊导管与传统球囊血管成形术治疗裸金属支架再狭窄和药物洗脱支架再狭窄患者的多中心随机对照研究”评论的回复
Am Heart J. 2014 Mar;167(3):e11. doi: 10.1016/j.ahj.2013.11.008. Epub 2013 Nov 23.
9
Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.光学相干断层扫描(OCT)在经皮冠状动脉介入治疗(PCI)中的支架内再狭窄(ISR):SEDUCE 研究(药物洗脱球囊在冠状动脉再狭窄中的安全性和疗效)的原理和设计。
EuroIntervention. 2011 May;7 Suppl K:K100-5. doi: 10.4244/EIJV7SKA17.
10
Extremely Late Catch-Up Phenomenon After First-Generation Sirolimus-Eluting Stent in the Left Main Stem: Insights From Optical Coherence Tomography.第一代西罗莫司洗脱支架植入左主干后极晚期追赶现象:光学相干断层扫描的见解
JACC Cardiovasc Interv. 2015 Dec 21;8(14):e237-9. doi: 10.1016/j.jcin.2015.06.031.

引用本文的文献

1
Stent Failure Management in Contemporary Clinical Practice.当代临床实践中的支架故障处理
Diagnostics (Basel). 2025 Jul 4;15(13):1709. doi: 10.3390/diagnostics15131709.
2
Effectiveness of directional coronary atherectomy in treating recurrent in-stent restenosis: a case report.定向冠状动脉斑块旋切术治疗支架内再狭窄的有效性:一例报告
Eur Heart J Case Rep. 2024 May 14;8(8):ytae233. doi: 10.1093/ehjcr/ytae233. eCollection 2024 Aug.
3
SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis.
SCAI关于支架内再狭窄和支架血栓形成管理的专家共识声明。
J Soc Cardiovasc Angiogr Interv. 2023 May 18;2(4):100971. doi: 10.1016/j.jscai.2023.100971. eCollection 2023 Jul-Aug.
4
A homogenized constrained mixture model of restenosis and vascular remodelling after balloon angioplasty.球囊血管成形术后再狭窄和血管重塑的均匀化约束混合模型。
J R Soc Interface. 2021 May;18(178):20210068. doi: 10.1098/rsif.2021.0068. Epub 2021 May 5.
5
A Biodegradable Mg-Based Alloy Inhibited the Inflammatory Response of THP-1 Cell-Derived Macrophages Through the TRPM7-PI3K-AKT1 Signaling Axis.一种可生物降解的镁基合金通过 TRPM7-PI3K-AKT1 信号通路抑制 THP-1 细胞衍生的巨噬细胞的炎症反应。
Front Immunol. 2019 Dec 3;10:2798. doi: 10.3389/fimmu.2019.02798. eCollection 2019.
6
Drug-eluting balloons versus new generation drug-eluting stents for the management of in-stent restenosis: an updated meta-analysis of randomized studies.药物洗脱球囊与新一代药物洗脱支架治疗支架内再狭窄的比较:随机研究的最新荟萃分析
J Geriatr Cardiol. 2019 Jun;16(6):448-457. doi: 10.11909/j.issn.1671-5411.2019.06.002.
7
Mediating effect of illness perception on the relationship between Type D personality and health behaviors among coronary artery disease patients.疾病认知在冠心病患者D型人格与健康行为关系中的中介作用。
Health Psychol Open. 2018 Dec 12;5(2):2055102918817228. doi: 10.1177/2055102918817228. eCollection 2018 Jul-Dec.
8
Association Between TG-to-HDL-C Ratio and In-Stent Stenosis Under Optical Coherence Tomography Guidance.基于光学相干断层扫描指导的 TG/HDL-C 比值与支架内狭窄的相关性。
J Med Syst. 2018 Nov 20;43(1):4. doi: 10.1007/s10916-018-1119-y.
9
Towards non-invasive characterisation of coronary stent re-endothelialisation - An in-vitro, electrical impedance study.朝向冠状动脉支架再内皮化的无创特征化——一项体外电阻抗研究。
PLoS One. 2018 Nov 5;13(11):e0206758. doi: 10.1371/journal.pone.0206758. eCollection 2018.
10
The relationship of Charlson comorbidity index with stent restenosis and extent of coronary artery disease.查尔森合并症指数与支架再狭窄及冠状动脉疾病程度的关系。
Interv Med Appl Sci. 2018 Jun;10(2):70-75. doi: 10.1556/1646.10.2018.20.